CME

 

CME Credit/certificates

Claim CME Credit and print your CME Certificate and/or Certificate of Attendance online now.

ACCREDITATION

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this educational activity for a maximum of 33.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Please note: Oral and poster sessions at ENDO are not eligible for CME credit.

STATEMENT OF NEED

Endocrinologists need a thorough knowledge of the most up-to-date developments and techniques in endocrinology to ensure the highest possible standard of patient care.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Discuss state-of-the-art research in endocrinology 
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, and adrenal, lipid, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae
  • Apply updated knowledge and clinical skills in improving patient care

TARGET AUDIENCE

This continuing medical education activity should be of substantial interest to:

  • Endocrinologists
  • Pediatric Endocrinologists
  • Internists
  • Clinical researchers
  • Other endocrine professionals

DISCLAIMER

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of The Endocrine Society.

DISCLOSURE POLICY

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, it is The Endocrine Society's policy to ensure that the contents and quality of this educational activity are balanced, independent, objective, and scientifically rigorous.  All faculty, committee members, and staff in control of content for this CME activity are required to disclose to the learners any relevant financial relationship(s) that have occurred in the past 12 months with any commercial interest(s) whose products or services are discussed in the CME content.   Such relationships are defined by remuneration in the form of grants; research support; consulting fees; salary; ownership interest (e.g. stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payment for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. 

The intent of this disclosure is not to prevent a speaker with relevant financial relationships from making a presentation but rather to provide learners with information on which they can make their own judgments.  It remains for the learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all faculty, planning committee, and staff disclosures and resolved or managed all identified conflicts of interest, as applicable.
Faculty, committee member, and staff disclosures will be published in the ENDO 2010 program materials.

POLICY ON UNLABELED/OFF-LABEL USAGE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial products is informative for audiences and therefore requires that speakers disclose this information to the learners at the beginning of their presentations.

Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such "off-label" uses be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis.  Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Acknowledgement of Commercial Support

This activity is supported by various commercial entities. As of May 24, 2010, the following companies have provided educational grant support for ENDO 2010:

  • Abbott Laboratories
  • Allergan, Inc.
  • Amgen
  • Auxilium Pharmaceuticals, Inc.
  • Bristol-Myers Squibb and AstraZeneca LP
  • Corcept Therapeutics
  • Daiichi Sankyo, Inc.
  • EMD Serono
  • Genentech
  • Genzyme Corporation
  • HOLOGIC
  • Ipsen
  • Lilly USA, LLC
  • Medtronic Diabetes
  • Merck
  • Novartis Pharmaceuticals Corporation
  • Novo Nordisk, Inc.
  • sanofi-aventis U.S.
  • Solvay Pharmaceuticals, Inc. (Solvay is now Abbott)

CONFLICT OF INTEREST STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas, Elements, Updated Criteria for Accreditation, and Policies of the ACCME. The ENDO 2010 scientific program was developed by the Annual Meeting Steering Committee prior to and independently of education grant support. 

The commercial supporters of this meeting have no influence over educational content or selection of speakers.  Educational grants support the overall meeting and are not used to compensate speakers in supported sessions. 

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.